Skip to main content
Clinical Trials/NCT06437262
NCT06437262
Completed
Phase 1

Randomized Clinical Trial on the Immediate Antibacterial Effect and Substantivity of a Single Application of a New Chlorhexidine Gel on Oral Biofilm and Saliva

University of Santiago de Compostela1 site in 1 country30 target enrollmentSeptember 1, 2022

Overview

Phase
Phase 1
Intervention
0.20% CHX gel on saliva
Conditions
Healthy
Sponsor
University of Santiago de Compostela
Enrollment
30
Locations
1
Primary Endpoint
Intragel bacterial viability: baseline vs 5 minutes
Status
Completed
Last Updated
last year

Overview

Brief Summary

The objective of this project was to compare the immediate antimicrobial effect and in situ substantivity of a new 0.20% chlorhexidine (CHX) gel and cymenol with the current CHX gel formulation on dental plaque biofilm and salivary flora up to 7 hours after a single application.

Registry
clinicaltrials.gov
Start Date
September 1, 2022
End Date
July 31, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Inmaculada Tomás

Professor

University of Santiago de Compostela

Eligibility Criteria

Inclusion Criteria

  • Systemically healthy volunteers
  • Age between 20-45 years
  • Presence of minimum 24 permanent teeth
  • No evidence of gingivitis or periodontitis (CPITN= 0)
  • No presence of untreated caries at the start of the study

Exclusion Criteria

  • Smoker or ex-smoker
  • Presence of dental protheses or orthodontic appliances
  • Antibiotic treatment and/or routine use of oral antiseptics in the previous three months
  • Presence of any systemic disease that could alter saliva production or composition

Arms & Interventions

0.20% CHX gel

Participants underwent a single application of the 0.20% CHX gel. Samples were collected in basal conditions (i.e., before application) and at 5 minutes, 1 hour, 3 hours, 5 hours and 7 hours after application.

Intervention: 0.20% CHX gel on saliva

0.20% CHX gel

Participants underwent a single application of the 0.20% CHX gel. Samples were collected in basal conditions (i.e., before application) and at 5 minutes, 1 hour, 3 hours, 5 hours and 7 hours after application.

Intervention: 0.20% CHX gel on oral biofilm

0.20% CHX and Cymenol gel

Participants underwent a single application of the 0.20% CHX + Cymenol gel. Samples were collected in basal conditions (i.e., before application) and at 5 minutes, 1 hour, 3 hours, 5 hours and 7 hours after application.

Intervention: 0.20% CHX and Cymenol gel on saliva

0.20% CHX and Cymenol gel

Participants underwent a single application of the 0.20% CHX + Cymenol gel. Samples were collected in basal conditions (i.e., before application) and at 5 minutes, 1 hour, 3 hours, 5 hours and 7 hours after application.

Intervention: 0.20% CHX and Cymenol gel on oral biofilm

Outcomes

Primary Outcomes

Intragel bacterial viability: baseline vs 5 minutes

Time Frame: Baseline, 5 minutes

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) with either 0.20% CHX gel or 0.20% CHX and cymenol gel: baseline vs 5 minutes

Intragel bacterial viability: baseline vs 5 hours

Time Frame: Baseline, 5 hours

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) with either 0.20% CHX gel or 0.20% CHX and cymenol gel: baseline vs 5 hours

Intragel bacterial viability: 5 minutes vs 7 hours

Time Frame: 5 minutes, 7 hours

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) with either 0.20% CHX gel or 0.20% CHX and cymenol gel: 5 minutes vs 7 hours

Intergel bacterial viability after 3 hours: 0.20% CHX gel vs 0.20% CHX and cymenol gel

Time Frame: 3 hours

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) after 3 hours: 0.20% CHX gel vs 0.20% CHX and cymenol gel.

Intergel bacterial viability at baseline: 0.20% CHX gel vs 0.20% CHX and cymenol gel

Time Frame: Baseline

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) at baseline: 0.20% CHX gel vs 0.20% CHX and cymenol gel.

Intragel bacterial viability: baseline vs 3 hours

Time Frame: Baseline, 3 hours

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) with either 0.20% CHX gel or 0.20% CHX and cymenol gel: baseline vs 3 hours

Intergel bacterial viability after 1 hour: 0.20% CHX gel vs 0.20% CHX and cymenol gel

Time Frame: 1 hour

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) after 1 hour: 0.20% CHX gel vs 0.20% CHX and cymenol gel.

Intragel bacterial viability: baseline vs 1 hour

Time Frame: Baseline, 1 hour

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) with either 0.20% CHX gel or 0.20% CHX and cymenol gel: baseline vs 1 hour

Intragel bacterial viability: baseline vs 7 hours

Time Frame: Baseline, 7 hours

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) with either 0.20% CHX gel or 0.20% CHX and cymenol gel: baseline vs 7 hours

Intragel bacterial viability: 5 minutes vs 5 hours

Time Frame: 5 minutes, 5 hours

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) with either 0.20% CHX gel or 0.20% CHX and cymenol gel: 5 minutes vs 5 hours

Intragel bacterial viability: 5 minutes vs 1 hour

Time Frame: 5 minutes, 1 hour

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) with either 0.20% CHX gel or 0.20% CHX and cymenol gel: 5 minutes vs 1 hour

Intragel bacterial viability: 5 minutes vs 3 hours

Time Frame: 5 minutes, 3 hours

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) with either 0.20% CHX gel or 0.20% CHX and cymenol gel: 5 minutes vs 3 hours

Intergel bacterial viability after 5 hours: 0.20% CHX gel vs 0.20% CHX and cymenol gel

Time Frame: 5 hours

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) after 5 hours: 0.20% CHX gel vs 0.20% CHX and cymenol gel.

Intergel bacterial viability after 7 hours: 0.20% CHX gel vs 0.20% CHX and cymenol gel

Time Frame: 7 hours

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) after 7 hours: 0.20% CHX gel vs 0.20% CHX and cymenol gel.

Intergel bacterial viability after 5 min: 0.20% CHX gel vs 0.20% CHX and cymenol gel

Time Frame: 5 minutes

Percentage of bacterial viability (Ratio of viable bacteria to total bacteria -viable + non-viable- multiplied by 100) after 5 minutes: 0.20% CHX gel vs 0.20% CHX and cymenol gel.

Study Sites (1)

Loading locations...

Similar Trials